- Home
- Curetis Starts Subsidiary Ares Genetics To Advance Genetic Antibiotic Resistance Testing
Press release
Curetis Starts Subsidiary Ares Genetics to Advance Genetic Antibiotic Resistance Testing
06 Apr 2017 08:30 CEST
Company Name
CURETIS
ISIN
NL0011509294
Connect_20170406_curetis_pr_ares_genetics_en_approved.pdf
Connect_20170406_curetis_pr_ares_genetics_de_approved.pdf